Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Verve Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
Revenues1.9130.10.068.20.00.0
            Revenue growth 90.7%    
Cost of goods sold0.0167.60.087.10.00.0
Gross profit1.9-37.50.0-18.90.00.0
            Gross margin100.0%-28.9% -27.7%  
Research and development130.1 68.2 35.411.1
General and administrative37.537.518.918.95.32.5
EBIT-165.7-165.7-87.1-87.1-40.6-13.6
            EBIT margin-8536.2%-127.4% -127.7%  
Pre-tax income-157.3-157.3-120.3-120.3-45.7-19.3
Income taxes0.10.10.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income-157.4-157.4-120.3-120.3-45.7-19.3
            Net margin-8108.6%-121.0% -176.4%  
 
Diluted EPS($2.91)($2.91)($4.48)($4.48)($20.31)($15.11)
Shares outstanding (diluted)54.054.126.926.92.31.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy